Gene Vector Market Size, Share, By Vector Type, Therapeutic Area, Application, End-User, and Region - Trends, Analysis, and Forecast till 2035

Gene vectors are essential tools in molecular biology, serving as vehicles to transfer genetic material into host cells. The target market growth is driven by the increasing demand for advanced genetic therapies particularly in treating genetic disorders, cancers and infectious diseases.

Gene Vector Market Report Highlights:

• The gene vector market size will expand to USD 2497.4 million by 2035.
• The market was valued at reached USD 927.2 million in 2024.
• The market demonstrates an annual growth rate of 11.5%.
• North America held the largest share of the market in 2024.
• Asia Pacific is expected to be the fastest-growing market during the forecast period.
• Under vector type, the viral vectors segment is expected to dominate the market during the forecast period.
• By application, the gene therapy segment is leading the market.
• On the basis of end-user, the contract development and manufacturing organizations (CDMOs) segment holds the largest gene vector market share.

Gene Vector Market Key Highlights:

• In December 2024, The Medical Research Council (MRC), part of UKRI, is launching its first two Centres of Research Excellence (CoRE), which will develop transformative new advanced therapeutics for currently untreatable diseases. Oxford is leading one of these Centres and co-leading the other. Together, these international collaborations will receive up to £50 million each over 14 years.
• In May 2024, SK pharmteco, a global contract development, manufacturing, and analytical testing organization serving the pharmaceutical and cell & gene therapy industry, announced the upcoming launch of Lentiviral Vector (LVV) Analytical Services, a comprehensive suite of analytical testing solutions specifically designed for LVV and cell therapy programs.

Browse ∼40 market data tables and ∼38 figures through ∼177 slides and in-depth TOC on “Gene Vector Market Size, Share, By Vector Type, Therapeutic Area, Application, End-User, and Region - Trends, Analysis, and Forecast till 2035”

Gene Vector Market Competitive Landscape:

The key players in the gene vector market are Thermo Fisher Scientific Inc., Merck KGaA, SK pharmteco Inc., Lonza Group, Catalent, Cobra Biologics, Genezen Laboratories, RegenxBio, Charles River Laboratories, Fujifilm Diosynth Biotechnologies, Kaneka Eurogentec SA, uniQure NV, Alnylam Pharmaceuticals, Amgen, Bluebird Bio, and Novartis.

Segmentation:

By Vector Type:

• Viral Vectors
• Non-Viral Vectors
• Exosomes
• Others

By Therapeutic Area:

• Neurology
• Oncology
• Hepatology
• Genetic Disorders
• Infectious Diseases
• Others

By Application:

• Gene Therapy
• Cell Therapy
• Vaccine Development
• Others

By End User:

• Research Institutes
• Contract Research Organizations (CROs)
• Contract Development and Manufacturing Organizations (CDMOs)
• Other End Users

By Region:

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• Indonesia
• Malaysia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East & Africa
• GCC
• Israel
• South Africa
• Rest of Middle East & Africa